Telemedical support in patients with chronic heart failure: experience from different projects in Germany.
The great epidemiological significance and costs associated with chronic heart failure pose a challenge to health systems in Western industrial countries. In the past few years, controlled randomised studies have shown that patients with chronic heart failure benefit from telemedical monitoring; specifically, telemonitoring of various vital parameters combined with a review of the symptoms, drug compliance and patient education. In Germany, various telemedical monitoring projects for patients with chronic heart failure have been initiated in the past few years; seven of them are presented here. Currently 7220 patients are being monitored in the seven selected projects. Most patients (51.1%) are in NYHA stage II, 26.3% in NYHA stage III, 14.5% in NYHA stage I and only 6.6% in NYHA stage IV respectively. Most projects are primarily regional. Their structure of telemedical monitoring tends to be modular and uses stratification according to the NYHA stages. All projects include medical or health economics assessments. The future of telemedical monitoring projects for patients with chronic heart failure will depend on the outcome of these assessments. Only of there is statistical evidence for medical benefit to the individual patient as well as cost savings will these projects continue.
Müller
Axel
A
Clinic of Internal Medicine, Chemnitz Hospital, Bürgerstrasse 2, 09113 Chemnitz, Germany.
Schweizer
Johannes
J
Helms
Thomas M
TM
Oeff
Micheal
M
Sprenger
Claudia
C
Zugck
Christian
C
Circulation. 2006 Feb 14;113(6):799-805
16461823
Dtsch Med Wochenschr. 2007 Mar 2;132(9):417-22
17315117
Am Heart J. 2003 Oct;146(4):705-12
14564327
Heart. 2005 Jul;91(7):899-906
15958358
Am J Cardiol. 2001 Aug 15;88(4):382-7
11545758
Eur J Heart Fail. 2009 Mar;11(3):319-25
19174529
Dtsch Med Wochenschr. 2007 Mar 2;132(9):458-60
17315125
Circulation. 2005 Jan 18;111(2):179-85
15642765
Dtsch Arztebl Int. 2009 Apr;106(16):269-75
19547628
Eur J Heart Fail. 2005 Dec;7(7):1133-44
16198629
Eur Heart J. 2008 Oct;29(19):2388-442
18799522
Eur J Heart Fail. 2008 Dec;10(12):1236-45
18996739
Lancet. 2002 Nov 23;360(9346):1631-9
12457785
Herzschrittmacherther Elektrophysiol. 2005 Sep;16(3):150-8
16177941
Eur Heart J. 2009 Jul;30(13):1666-73
19411662
Eur J Heart Fail. 2005 Mar 16;7(3):423-8
15718184
Circulation. 1991 Jul;84(1):40-8
2060110
Am Heart J. 2005 Apr;149(4):722-9
15990759
Z Kardiol. 2005 Aug;94(8):488-509
16049651
Eur J Heart Fail. 2003 Oct;5(5):583-90
14607195
J Am Coll Cardiol. 2005 May 17;45(10):1654-64
15893183
Clin Res Cardiol. 2006 Jan;95 Suppl 2:II37-40
16598571
Herz. 2007 Dec;32(8):623-9
18060608
BMJ. 2007 May 5;334(7600):942
17426062
Eur J Heart Fail. 2001 Jun;3(3):315-22
11378002
Int J Cardiol. 2004 Oct;97(1):49-55
15336806
J Am Coll Cardiol. 1995 Nov 15;26(6):1417-23
7594064
Eur Heart J. 2006 Feb;27(4):434-40
16230302
Eur J Heart Fail. 2009 Mar;11(3):312-8
19228800